All other professional, scientific and technical activities n.e.c.
EITRFARMA AS
Revenue 2024
NOK 127,000
Operating profit
NOK 88,000
Equity
NOK 68,000
Incorporated
2019
Share capital
NOK 50,000
Key figures · 2024
Current ratio
18.24
Equity ratio
46.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 69.1% | |
| Net margin (%%) | 62.8% | |
| Return on assets (%%) | 60.0% | |
| Likviditet | ||
| Current ratio | 18.24 | |
| Working capital | 138k | |
| Soliditet | ||
| Equity ratio (%%) | 46.6% | |
| Debt-to-equity ratio | 1.15 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.